Search
Co-Diagnostics Inc
CODXAdd to Watchlist
1.210USD
+0.060+5.22%
Market hours 08/21, 12:58（ET）
5.90MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-20The current earnings forecast score of Co-Diagnostics Inc is 6.00, ranking 171 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 1.25, with a high of 1.50 and a low of 1.00.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
4.000
Target Price
+69.49%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Co-Diagnostics Inc
CODX
2
Intuitive Surgical Inc
ISRG
34
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
32
Thermo Fisher Scientific Inc
TMO
32
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Co-Diagnostics Inc's expected revenue for the next quarter?
Co-Diagnostics Inc's expected revenue is 184.50K.
What is Co-Diagnostics Inc's price target?
Analysts forecast that Co-Diagnostics Inc's price target is USD 1.25, with the highest forecast at USD 1.50 and the lowest forecast at USD 1.00.
How have Co-Diagnostics IncCODX's recent earnings per share performed?
The market expectation was USD -1.46, while Co-Diagnostics IncCODX's earnings per share (EPS) for the previous quarter was USD -4.06. EPS for the next quarter is expected at USD -2.85.
What is the analyst rating for Co-Diagnostics Inc?
Based on the ratings of Co-Diagnostics Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.